Vaccine maker stocks fall as Trump taps RFK Jr. for health secretary
Add Axios as your preferred source to
see more of our stories on Google.
Vaccine company stocks fell sharply Thursday on reports that President-elect Donald Trump would nominate Robert F. Kennedy Jr. as secretary of health and human services.
Why it matters: Trump's pick, which was confirmed after markets closed, puts one of the nation's foremost vaccine skeptics in charge of America's health care agencies.
By the numbers: The stocks of Moderna, BioNTech and Novavax fell 5.6%, 7.1% and 7.0%, respectively Thursday.
- All three companies get significant revenue from COVID vaccines.
State of play: The "Make America Healthy Again" campaign, led by Kennedy, is built around conspiratorial concerns about the food supply, vaccines and the drug industry.
- Trump posted on Truth Social Thursday afternoon that HHS under Kennedy would "play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country."
Go deeper: Trump echoes Kennedy's vaccine conspiracies in leaked phone call
